New Targets for Molecular Therapy of Biliary Malignant Tumors
Biliary tract cancer is a group of epithelial cancers associated with the biliary tract. They are anatomically divided into intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA) subgroups. Up to now, surgical treatment is still the main treatment for malignant biliary tumors, but many patients are...
Main Authors: | LYU Hong, LYU Zhicheng, LIU Guangde |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-01-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.0473.htm |
Similar Items
-
Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?
by: Amol Gupta, et al.
Published: (2023-03-01) -
Advances in targeted therapy of cholangiocarcinoma
by: Yuhang Li, et al.
Published: (2024-12-01) -
Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine
by: Takafumi Mie, et al.
Published: (2024-02-01) -
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
by: Qin Liu, et al.
Published: (2023-01-01) -
Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers
by: Angela Lamarca, et al.
Published: (2020-09-01)